Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-15-043800
Filing Date
2015-02-11
Accepted
2015-02-11 14:16:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d870497dsc13ga.htm SC 13G/A 37504
  Complete submission text file 0001193125-15-043800.txt   39087
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Subject) CIK: 0001050007 (see all company filings)

EIN.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-55297 | Film No.: 15598790
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 181 BAY ST. SUITE 4510, BAY WELLINGTON TOWER TORONTO A6 M5J 2T3
Business Address 181 BAY ST. SUITE 4510, BAY WELLINGTON TOWER TORONTO A6 M5J 2T3 416-869-3222
Burgundy Asset Management Ltd. (Filed by) CIK: 0001315868 (see all company filings)

EIN.: 986054306 | State of Incorp.: A6 | Fiscal Year End: 0630
Type: SC 13G/A